- Home
- MRK vs TJX Comparison
MRK vs TJX Comparison
Compare MRK & TJX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | TJX |
|---|---|---|
| Founded | 2000 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 173.6B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRK | TJX |
|---|---|---|
| Price | $120.79 | $160.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 16 |
| Target Price | $125.59 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 6.9M | 5.3M |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | ★ 3.06% | 1.23% |
| EPS Growth | 8.01 | ★ 14.32 |
| EPS | N/A | ★ 1.19 |
| Revenue | ★ $65,011,000,000.00 | $29,078,407,000.00 |
| Revenue This Year | $3.61 | $6.75 |
| Revenue Next Year | $5.41 | $5.81 |
| P/E Ratio | ★ N/A | $133.27 |
| Revenue Growth | 1.31 | ★ 6.04 |
| 52 Week Low | $76.66 | $119.84 |
| 52 Week High | $125.14 | $165.82 |
Technical Indicators
Market Signals| Indicator | MRK | TJX |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 60.52 |
| Support Level | $112.49 | $153.31 |
| Resistance Level | $124.09 | $163.70 |
| Average True Range (ATR) | 2.82 | 3.56 |
| MACD | 0.45 | 0.76 |
| Stochastic Oscillator | 83.03 | 91.70 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TJX TJX Companies Inc. (The)
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2026, the company generated roughly $60 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.